glp 1 safe for kidneys Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist attenuating renal fibrosis Glucagon-like Peptide-1 Receptor Agonists: New

In one randomized control-trial comparing an L-carnitine supplementation group of patients with a group taking placebos, the treatment group experienced a significant reduction in body fat compared to placebo (-3.1kg vs -0.5kg) 1

The peptide shows potential for reducing central sensitization, a key driver of chronic pain

View Study [5]"Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris" Lu Z, Liu N, et al., 2023 Finding: Purified LR3 IGF-1 displayed excellent bioactivity for cell proliferation comparable to standard IGF-1, confirming that the molecular modifications preserve its biological function while extending its active lifespan